SOLACI-SOCIME 2022 | Closure of the LAA: My Best Case and Worst Case, by Dr. Aníbal Damonte

Read the most outstanding articles from the second day of the SOLACI-SOCIME 2022 Congress.

In this case, consult the presentation by Dr. Aníbal Damonte, entitled “Closure of the LAA: My Best Case and Worst Case

ago-5-damonte-2


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

SOLACI-SOCIME 2022 | Rol de los Dispositivos Fenestrados en Hipertensión Arterial Pulmonar, by Dr. Daniel Springmuller

Read the most outstanding articles from the second day of the SOLACI-SOCIME 2022 Congress. In this case, consult the presentation by Dr. Daniel Springmuller, entitled...

SOLACI-SOCIME 2022 | Pulsta Valve implantation : How do I do it?, by Dr. Alejandro Peirone

Read the most outstanding articles from the second day of the SOLACI-SOCIME 2022 Congress. In this case, consult the presentation by Dr. Alejandro Peirone, entitled...

SOLACI-SOCIME 2022 | El Desafío de PCI en pacientes con HBR, by Dr. Aníbal Damonte

Read the most outstanding articles from the second day of the SOLACI-SOCIME 2022 Congress. In this case, consult the presentation by Dr. Aníbal Damonte, entitled...

SOLACI-SOCIME 2022 | Treatment of STEMI with Cardiogenic Shock: PCI and MCS Selection and Timing, por el Dr. Mauricio Cohen

Read the most outstanding articles from the first day of the SOLACI-SOCIME 2022 Congress. In this case, consult the presentation by Dr. Mauricio Cohen, entitled...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....